Drug Repurposing for COVID-19
Dr. Jean Bourbeau is leading a new Phase III clinical trial with dapson to target lung inflammation caused by COVID-19
Posts and information on COVID-19 for Meakins-Christie, RECRU, and RESP members.
Dr. Jean Bourbeau is leading a new Phase III clinical trial with dapson to target lung inflammation caused by COVID-19
Dr. Peter Goldberg receives an Innovation grant to build a clinical-grade ventilator that can be produced cheaply and easily
Dr. Goldberg in La Presse – COVID-19 patients’ experiences post-ICU: enduring side effects and a long recovery.
Dr. Carolyn Baglole received a CIHR catalyst grant from the recent Health Effects of Vaping competition
Dr. Maziar Divangahi asserts that only a team effort across scientific disciplines will lead to the elimination of SARS-CoV-2.
Thanks to Adomo Donovan and the ICU Bridge Program, the MUHC’s ICU staff are now recognizable despite their PPE.
A new clinical trial, designed by Drs. Ezer, Martin, Benedetti & Smith, will test ciclesonide in the early stages of COVID-19.
Dr. Jean Bourbeau receives funding from the CIHR COVID-19 Rapid Research Funding Opportunity.
Read an opinion piece by Dr. Dick Menzies: How to focus testing and help eliminate the spread of COVID-19.
Dr. Dick Menzies calls for a more extensive and ultimately less expensive approach to COVID-19 testing for all Canadians.